188 related articles for article (PubMed ID: 29494827)
1. Anal squamous cell carcinoma - State of the art management and future perspectives.
Martin D; Balermpas P; Winkelmann R; Rödel F; Rödel C; Fokas E
Cancer Treat Rev; 2018 Apr; 65():11-21. PubMed ID: 29494827
[TBL] [Abstract][Full Text] [Related]
2. The immune microenvironment and HPV in anal cancer: Rationale to complement chemoradiation with immunotherapy.
Martin D; Rödel F; Balermpas P; Rödel C; Fokas E
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):221-230. PubMed ID: 28501560
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma.
Cabel L; Jeannot E; Bieche I; Vacher S; Callens C; Bazire L; Morel A; Bernard-Tessier A; Chemlali W; Schnitzler A; Lièvre A; Otz J; Minsat M; Vincent-Salomon A; Pierga JY; Buecher B; Mariani P; Proudhon C; Bidard FC; Cacheux W
Clin Cancer Res; 2018 Nov; 24(22):5767-5771. PubMed ID: 30054279
[No Abstract] [Full Text] [Related]
4. Chemoradiotherapy for anal cancer: are we as good as we think?
Martin D; Rödel C; Fokas E
Strahlenther Onkol; 2019 May; 195(5):369-373. PubMed ID: 30937508
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in anal cancer: from biological understanding to stratified treatment.
Jones CM; Goh V; Sebag-Montefiore D; Gilbert DC
Br J Cancer; 2017 Jan; 116(2):156-162. PubMed ID: 27923035
[TBL] [Abstract][Full Text] [Related]
6. The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer.
Kochhar R; Renehan AG; Mullan D; Chakrabarty B; Saunders MP; Carrington BM
Eur Radiol; 2017 Feb; 27(2):607-617. PubMed ID: 27090113
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
[TBL] [Abstract][Full Text] [Related]
8. A 2020 update of anal cancer: the increasing problem in women and expanding treatment landscape.
Lum C; Prenen H; Body A; Lam M; Segelov E
Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):665-680. PubMed ID: 32458709
[TBL] [Abstract][Full Text] [Related]
9. The Management and Prevention of Anal Squamous Cell Carcinoma.
Eng C; Messick C; Glynne-Jones R
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():216-225. PubMed ID: 31099616
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy in Anal Cancer.
Dhawan N; Afzal MZ; Amin M
Curr Oncol; 2023 Apr; 30(5):4538-4550. PubMed ID: 37232801
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG).
Martin D; Schreckenbach T; Ziegler P; Filmann N; Kalinauskaite G; Tinhofer I; Budach V; Gani C; Zips D; Schimek-Jasch T; Schäfer H; Grosu AL; Thomas E; Krause M; Dapper H; Combs S; Hoffmann C; Stuschke M; Walter F; Belka C; Kurth I; Hadiwikarta WW; Baumann M; Rödel C; Fokas E
Radiother Oncol; 2022 Feb; 167():233-238. PubMed ID: 34999135
[TBL] [Abstract][Full Text] [Related]
12. Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.
Oliveira SC; Moniz CM; Riechelmann R; Alex AK; Braghirolli MI; Bariani G; Nahas C; Hoff PM
J Gastrointest Cancer; 2016 Mar; 47(1):75-81. PubMed ID: 26691173
[TBL] [Abstract][Full Text] [Related]
13. Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
Mouw KW; Cleary JM; Reardon B; Pike J; Braunstein LZ; Kim J; Amin-Mansour A; Miao D; Damish A; Chin J; Ott PA; Fuchs CS; Martin NE; Getz G; Carter S; Mamon HJ; Hornick JL; Van Allen EM; D'Andrea AD
Clin Cancer Res; 2017 Jun; 23(12):3214-3222. PubMed ID: 27852700
[No Abstract] [Full Text] [Related]
14. Anal cancer treatment: current status and future perspectives.
Ghosn M; Kourie HR; Abdayem P; Antoun J; Nasr D
World J Gastroenterol; 2015 Feb; 21(8):2294-302. PubMed ID: 25741135
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy.
Hocquelet A; Auriac T; Perier C; Dromain C; Meyer M; Pinaquy JB; Denys A; Trillaud H; Denis De Senneville B; Vendrely V
Eur Radiol; 2018 Jul; 28(7):2801-2811. PubMed ID: 29404766
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiotherapy for anal squamous cell carcinoma.
Houlihan OA; O'Neill BD
Surgeon; 2016 Aug; 14(4):202-12. PubMed ID: 27118047
[TBL] [Abstract][Full Text] [Related]
17. Long-standing Crohn's disease and its implication on anal squamous cell cancer management.
Lightner AL; Moncrief SB; Smyrk TC; Pemberton JH; Haddock MG; Larson DW; Dozois EJ; Mathis KL
Int J Colorectal Dis; 2017 May; 32(5):661-666. PubMed ID: 28293746
[TBL] [Abstract][Full Text] [Related]
18. Polo-like kinase 3 and phosphoT273 caspase-8 are associated with improved local tumor control and survival in patients with anal carcinoma treated with concomitant chemoradiotherapy.
Rödel F; Martin D; Helmke C; Balermpas P; Fokas E; Wieland U; Rave-Fränk M; Kitz J; Matthess Y; Raab M; Strebhardt K; Rödel C
Oncotarget; 2016 Aug; 7(33):53339-53349. PubMed ID: 27462786
[TBL] [Abstract][Full Text] [Related]
19. Analysis of outcomes achieved with squamous cell carcinomas of the anus in a single university hospital over the last two decades: Clinical response rate, relapse and survival of 190 patients.
Gravante G; Stephenson JA; Elshaer M; Osman A; Vasanthan S; Mullineux JH; Gani MAD; Sharpe D; Yeung J; Norwood M; Miller A; Boyle K; Hemingway D
J Surg Oncol; 2018 Feb; 117(2):269-274. PubMed ID: 28891266
[TBL] [Abstract][Full Text] [Related]
20. [Treatment Outcome of Anal Squamous Cell Carcinoma Treated with Radical Chemoradiotherapy].
Sato H; Koide Y; Shiota M; Morise Z; Maeda K; Uyama I
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1708-1710. PubMed ID: 28133106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
